Aytu BioScience Inc
Aytu BioPharma, Inc., a pharmaceutical company, focuses on commercializing novel therapeutics in the United States and internationally. The company offers prescription products for the treatment of attention deficit hyperactivity disorder (ADHD), including Adzenys XR-ODT extended-release orally disintegrating tablets for patients from six years of age and above; Cotempla XR-ODT extended-release o… Read more
Aytu BioScience Inc (AYTU) - Cash Flow Conversion Efficiency
Latest cash flow conversion efficiency as of December 2025: 0.259x
Based on the latest financial reports, Aytu BioScience Inc (AYTU) has a cash flow conversion efficiency ratio of 0.259x as of December 2025.
Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow ($3.67 Million) by net assets ($14.20 Million). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations.
Aytu BioScience Inc - Cash Flow Conversion Efficiency Trend (2007–2025)
This chart illustrates how Aytu BioScience Inc's cash flow conversion efficiency has evolved over time, based on yearly financial data. Explore and compare other companies by cash flow conversion efficiency.
Aytu BioScience Inc Competitors by Cash Flow Conversion Efficiency
The table below lists competitors of Aytu BioScience Inc ranked by their cash flow conversion efficiency.
| Company | Cash Flow Conversion Efficiency |
|---|---|
|
Intergis
KO:129260
|
0.044x |
|
Jameson Resources Ltd
AU:JAL
|
0.005x |
|
Sastasundar Ventures Limited
NSE:SASTASUNDR
|
-0.031x |
|
Xin Chio Global Co Ltd
TWO:3171
|
0.050x |
|
Venator Materials PLC
PINK:VNTRF
|
-0.732x |
|
Takarék Jelzálogbank Nyrt
F:FH21
|
-0.134x |
|
Ogunsen AB Series B
ST:OGUN-B
|
-0.035x |
|
SAN LEON ENERGY EO -01
F:SZX1
|
N/A |
Annual Cash Flow Conversion Efficiency for Aytu BioScience Inc (2007–2025)
The table below shows the annual cash flow conversion efficiency of Aytu BioScience Inc from 2007 to 2025.
| Year | Net Assets | Operating Cash Flow | Cash Flow Conversion Efficiency | Change |
|---|---|---|---|---|
| 2025-06-30 | $18.97 Million | $-1.94 Million | -0.102x | -103.94% |
| 2024-06-30 | $27.72 Million | $-1.39 Million | -0.050x | +61.57% |
| 2023-06-30 | $39.36 Million | $-5.13 Million | -0.130x | +79.97% |
| 2022-06-30 | $44.31 Million | $-28.82 Million | -0.651x | -244.67% |
| 2021-06-30 | $137.57 Million | $-25.96 Million | -0.189x | +36.80% |
| 2020-06-30 | $95.02 Million | $-28.37 Million | -0.299x | +84.70% |
| 2019-06-30 | $7.09 Million | $-13.83 Million | -1.951x | -64.34% |
| 2018-06-30 | $13.42 Million | $-15.94 Million | -1.187x | +65.66% |
| 2017-06-30 | $4.00 Million | $-13.83 Million | -3.458x | -227.19% |
| 2016-06-30 | $10.09 Million | $-10.66 Million | -1.057x | -148.75% |
| 2015-06-30 | $15.62 Million | $-6.63 Million | -0.425x | +58.54% |
| 2014-06-30 | $5.37 Million | $-5.50 Million | -1.025x | -401.27% |
| 2013-06-30 | $-110.86K | $-37.70K | 0.340x | -37.35% |
| 2012-06-30 | $-69.72K | $-37.85K | 0.543x | -70.19% |
| 2011-06-30 | $-35.59K | $-64.82K | 1.821x | +133.46% |
| 2010-06-30 | $-55.61K | $-43.38K | 0.780x | -77.28% |
| 2009-06-30 | $-13.58K | $-46.63K | 3.433x | +298.92% |
| 2008-06-30 | $25.96K | $-44.80K | -1.726x | -16.26% |
| 2007-06-30 | $18.81K | $-27.92K | -1.484x | -- |